IRIS
LUZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.679
AS - Asia 4.019
EU - Europa 2.184
SA - Sud America 888
Continente sconosciuto - Info sul continente non disponibili 307
AF - Africa 88
OC - Oceania 21
Totale 14.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.444
SG - Singapore 1.741
CN - Cina 962
IT - Italia 942
BR - Brasile 679
VN - Vietnam 451
IN - India 387
DE - Germania 360
GB - Regno Unito 273
SE - Svezia 154
FI - Finlandia 151
CA - Canada 146
AR - Argentina 87
HK - Hong Kong 85
NL - Olanda 83
BD - Bangladesh 74
IR - Iran 56
MX - Messico 51
ID - Indonesia 37
RU - Federazione Russa 37
TR - Turchia 35
EC - Ecuador 34
JP - Giappone 33
IQ - Iraq 25
PL - Polonia 25
ES - Italia 24
UA - Ucraina 22
ZA - Sudafrica 22
FR - Francia 21
PK - Pakistan 21
CL - Cile 20
CO - Colombia 20
AU - Australia 19
IL - Israele 17
CZ - Repubblica Ceca 15
TW - Taiwan 14
MA - Marocco 13
PY - Paraguay 13
PH - Filippine 11
UZ - Uzbekistan 11
VE - Venezuela 11
IE - Irlanda 10
PE - Perù 10
UY - Uruguay 10
AT - Austria 9
EG - Egitto 9
RO - Romania 9
RS - Serbia 8
CR - Costa Rica 7
KE - Kenya 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
CH - Svizzera 6
EU - Europa 6
DZ - Algeria 5
ET - Etiopia 5
GT - Guatemala 5
HU - Ungheria 5
OM - Oman 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BE - Belgio 4
BH - Bahrain 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
NG - Nigeria 4
NI - Nicaragua 4
NP - Nepal 4
PS - Palestinian Territory 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AO - Angola 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
LT - Lituania 3
MG - Madagascar 3
PT - Portogallo 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CG - Congo 2
CU - Cuba 2
HN - Honduras 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
Totale 13.873
Salva come PNG Salva come JPEG
Città #
San Jose 1.255
Ashburn 628
Singapore 563
Chandler 533
Santa Clara 344
Dallas 334
Council Bluffs 325
Munich 292
Bengaluru 275
Hefei 274
Milan 256
Chicago 241
Princeton 213
Lawrence 210
London 204
Ho Chi Minh City 177
Beijing 135
Wilmington 132
Hanoi 85
Helsinki 85
Ottawa 83
Phoenix 82
Los Angeles 80
Hong Kong 75
São Paulo 70
Des Moines 68
New York 53
Catanzaro 49
Turku 48
Rome 47
Boardman 46
Shanghai 38
Naples 34
Guangzhou 29
Redwood City 27
Mumbai 23
Cittanova 22
Hanover 22
Pune 22
San Francisco 22
Haiphong 21
Montreal 21
Da Nang 19
Norwalk 19
Brooklyn 18
Orem 17
Rio de Janeiro 17
The Dalles 17
Bari 16
Palermo 16
Redmond 16
Tokyo 16
Warsaw 16
Atlanta 15
Boston 15
Istanbul 15
Shenzhen 14
Belo Horizonte 13
Brasília 13
Chennai 13
Dhaka 13
Stockholm 13
Charlotte 12
Guayaquil 12
Mendicino 12
Mexico City 12
Osaka 12
Toronto 12
Amsterdam 11
Curitiba 11
Hải Dương 11
Jyväskylä 11
Buffalo 10
Campinas 10
Cosenza 10
Salt Lake City 10
Salvador 10
San Nicola Manfredi 10
Tashkent 10
Thái Nguyên 10
Biên Hòa 9
Miami 9
Montevideo 9
Olomouc 9
Praia A Mare 9
Dublin 8
Jiaxing 8
Johannesburg 8
Manchester 8
Philadelphia 8
Quito 8
Santo André 8
Tehran 8
Washington 8
Catania 7
Collegeville 7
Dulles 7
Fortaleza 7
Frankfurt am Main 7
Karachi 7
Totale 8.209
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 263
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 218
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials 134
Dietary polyphenolsand non-alcoholic fatty liver disease 112
Applications of Text Mining techniques to extract meaningful information from gastroenterology medical reports 110
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 104
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 96
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 95
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 89
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 88
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 86
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 86
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 84
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 84
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 83
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 81
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 81
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 81
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 80
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 80
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 79
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 79
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 78
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 78
The role of gluten-free diet in nonalcoholic fatty liver disease development 78
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 77
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 76
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 76
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 76
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 76
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 75
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 75
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 74
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 74
Tumeurs benignes et malignes du duodenum 71
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 71
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 70
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 70
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 70
Ancient wheats: beneficial effects on insulin resistance 70
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 70
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 69
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 69
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 69
Primary clarithromycin resistance in Helicobacter pylori: The multicentric Italian clarithromycin resistance observational (MICRO) study 68
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 68
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 68
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 67
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 66
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 66
Gut microbiota and non-alcoholic fatty liver disease 66
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 65
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 64
Machine Learning Approaches in Inflammatory Bowel Disease 63
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 63
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 62
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 62
Antibacterial drugs in Crohn's disease 62
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 61
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 61
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 61
Bioactive IL-18 expression is up-regulated in Crohn's disease 61
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 61
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 60
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 60
Liver injury associated with high value of D-dimer plasmatic level in COVID-19 patients 59
Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes 59
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 59
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 58
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 58
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 57
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 57
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 57
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 57
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 57
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 57
La calcolosi della colecisti 57
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 57
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 57
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells 57
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 56
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 56
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 56
Bone mineralization in celiac disease 56
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 55
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 55
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 55
Treatment with phosphatidylcholine of patients with nonalcoholic fatty liver disease: a prospective pilot study 54
Circulating D dimer in inflammatory bowel disease 54
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission 54
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 54
Evidence favouring the gastro-oral route in the transmission of Helicobacter pylori infection in children 54
Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease 53
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 53
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 53
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 53
Gut microbiota changes and chronic hepatitis C virus infection 53
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 52
Interleukin-12 is expressed and actively released by Crohn's desease intestinal lamina propria mononuclear cells 52
Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. 52
Totale 7.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.805
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022528 0 0 0 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.934 386 182 176 67 173 388 192 155 421 90 250 454
2025/20265.832 294 616 641 1.064 595 235 700 354 682 393 161 97
2026/20271.522 100 352 742 328 0 0 0 0 0 0 0 0
Totale 14.186